Ceres Ventures logo

Ceres Ventures(OTC) CEVE

Market Cap$7.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-98%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Ceres Ventures last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-11
Ceres Ventures stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-27
1 month+0%USD 0.002026-08-07
3 month+0%USD 0.002026-06-08
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-09-05
3 year+0%USD 0.002023-09-11
5 year-98%USD 0.012021-09-08
Since inception-99.98%USD 0.442011-12-30

Ceres Ventures Financials at a Glance

Market Cap

$7.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$668.09K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

284.69 (High)

Price

$0.00

Volume

29

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

CEVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ceres Ventures

Ceres Ventures, Inc. is an emerging clean technology firm focused on developing innovative environmental solutions for purifying contaminated water, soil, and air. The company specializes in advanced technologies that address critical environmental challenges while promoting sustainability.

Products and Services
  • BluFlow Nanoparticles for capturing and removing contaminants
  • Automated BluFlow Advanced Ultrafiltration Technology for clean water reclamation
  • Comprehensive BluFlow Treatment System for effective pollutant elimination
Growth Outlook
  • Increasing global demand for clean water solutions drives market potential
  • Technological advancements position the company for competitive advantage
  • Expanding applications in municipal and industrial sectors enhance growth opportunities
Financial Highlights
  • Recent quarterly net income of -$149,000 reflects ongoing investment in R&D
  • Trailing twelve months (TTM) revenue remains at $0, indicating growth phase
  • Current ratio of 0.21 suggests liquidity challenges but potential for improvement
Ceres Ventures, Inc. operates in the healthcare sector, specifically within the medical care facilities industry. The company is headquartered in New York City and has transitioned from its previous identity as PhytoMedical Technologies, Inc. in 2011. The focus on clean technology aligns with increasing global environmental concerns, making Ceres Ventures a relevant player in the market. The innovative product offerings, particularly the BluFlow technologies, are designed to meet the growing need for effective environmental remediation solutions. Despite current financial challenges, the company's strategic positioning and technological advancements suggest a promising outlook for future growth.
AI Generated • Sep 23, 2026

Industry

Commercial Services and Supplies

Headquarters

New York City, NY 10022, US

CEVE Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

225.93%

Return on Capital

N/A

Return on Assets

-346.69%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

77.09M

Volume

29

Avg. Volume

27.015

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$744.25K

EBITDA

-$744.25K

Operating Cash Flow

-$206.46K

Capital Expenditure

-$22.70K

Free Cash Flow

-$266.21K

Cash & ST Invst.

$4.81K

Total Debt

$200.48K

Ceres Ventures Performance Analysis

Ceres Ventures sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42011-12-31N/A
Q12012-03-31N/A
Q22012-06-30N/A
Q32012-09-30N/A
Ceres Ventures sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42011-12-31-138.9%
Q12012-03-3172.1%
Q22012-06-308.3%
Q32012-09-30-54.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2012YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$149.00K

-17.2%

EBITDA

-$122.00K

+3.9%

Quarterly Fundamentals

Name
Q3 2012YOY CHG

Total Cash

$4.81K

-68.1%

Total Debt

$200.48K

+97.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$138.48K

+9022.3%

Short Term Debt

$62.00K

-38.0%

Return on Assets

-3.47%

N/A

Return on Invested Capital

1.50%

N/A

Free Cash Flow

-$23.71K

+56.8%

Operating Cash Flow

-$14.51K

+71.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDITMedite Cancer Diagnostics, Inc.
$0.00+0.00%
RCARRenovaCare, Inc.
$0.00+0.00%
ASFXAmerican Scientific Resources, Incorporated
$0.00+0.00%
CBGIThe CannaBusiness Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$30.65+3.44%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$158.91-3.26%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$32.07+0.75%
IBITiShares Bitcoin Trust
$47.21-2.64%

Questions About CEVE

What is the current price of Ceres Ventures?

Ceres Ventures is trading at $0.00 per share.

What is the 52-week range for Ceres Ventures?

Over the past 52 weeks, Ceres Ventures has traded between $0.00 and $0.04.

How much debt does Ceres Ventures have?

Ceres Ventures total debt is unavailable.

How much cash does Ceres Ventures have on hand?

Ceres Ventures does not have cash on hand data available.

What is Ceres Ventures’s dividend yield?

Ceres Ventures does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.